Journal List > Kosin Med J > v.29(2) > 1057019

Kim, Kim, Kim, Ryu, Ryu, Lee, Jeon, Choi, and Kim: Pathological differences between forceps biopsy specimens and endoscopic resection specimens in early gastric cancer patients

Abstract

Objective:

Endoscopic resection(ER) is effective therapy on EGC and which is treated according to the histological diagnosis of forcep biopsy. But sometimes the histological diagnosis of forcep biopsy and post-ER does not match with each other and it might lead to wrong treatment. The aim of this study is to find the frequency of histologic differences between forcep biopsy and post-ER, and to confirm the characteristics of lesions which make errors.

Methods:

We selected the confirmed cancer cases of 141 patients of 1359 gastric tumor lesions which were treated under the ER in Eulji university hospital from May 2005 to March 2013. They were sorted by the age and sex of patient, location of lesion, present of ulcer and depression to identify the discordance between forcep biopsy and ER. The discordant group was compared with non-cancer-diagnosed controlled group, retrospectively.

Results:

70 cases(5.5%) of 1283 cases of “cancer negative” in forceps biopsy were fo䴸nd to be diagnosed cancer on final diagnosis of cancer by post-ER result. In this discordant group showed characteristics of bigger size that are with more frequently in tumor size D15mm(17.9% vs. 31.4%, p=0.03), have depressed lesion(ᄀ 4.3% vs. 41.4%, p<0.01) and have 䴸lceration(2.4% vs.18.6%, p<0.01) than that of 84 control gro䴸p not diagnosed cancer.

Conclusions:

In cases of tumor with size D15mm, presented with depressed lesion and ulceration, we should consider combined cancer, even the result of forcep biopsy was negative. Therefore, more careful and accurate resection should be taken with characters listed above.

REFERENCES

1.Choi KS., Jung HY. Endoscopic Resection of Early Gastric Cancer. J Korean Med Assoc. 2010. 53:299–305.
crossref
2.Gotoda T., Yanagisawa A., Sasako Μ., Ono H., Nakanishi Y., Shimoda T, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000. 3:219–25.
crossref
3.Jung MK., Jeon SW., Park SY., Cho CM, Tak WY., Kweon YO, et al. Endoscopic characteristics of gastric adenomas suggesting carcinomatous transformation. Surg Endosc. 2008. 22:2705–11.
crossref
4.Rosch W,Elster K., Ottenjann R. Diagnosis of gastric polyps by means of endoscopic biopsy. Minerva Med. 1972. 63:4145–7.
5.Palli D., Bianchi S., Cipriani F., Duca P., Amorosi A., Avellini C, et al. Reproducibility of histologic classification of gastric cancer. Br J Cancer. 1991. 63:765–8.
crossref
6.Ichiyoshi Y., Toda T., Minamisono Y., Nagasaki S., Yakeishi Y., Sugimachi K. Recurrence in early gastric cancer. Surgery. 1990. 107:489–95.
7.Hakim NS., Sarr MG., van Heerden JA. Does endoscopy really help the surgeon evaluate gastric cancer? Can J Surg. 1989. 32:175–7.
8.Namieno T., Koito K., Higashi T., Shimamura T., Yamashita K., Sato N, et al. Assessing the suitability of gastric carcinoma for limited resection: histologic differentiation of endoscopic biopsy. World J Surg. 1998. 22:865–8.
crossref
9.Participants in the Paris workshop. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003. 58:S3–43.
10.Hamilton SR., Aaltonen LA. WHO Classification of Tumors. Pathology and Genetics of Tumors of the Digestive System. Lyon: IARC Press;2000.
11.Muehldorfer SM., Stolte M., Martus P., Hahn EG., Ell C. Multicenter study Group “Gastric Polyps”. Diagnostic accuracy of forceps biopsy versus polypectomy for gastric polyps: a prospective multicentre study. Gut. 2002. 50:465–70.
crossref
12.Szaloki T., Toth V., Nemeth I., Tiszlavicz L., Lonovics J., Czako L. Endoscopic mucosal resection: not only therapeutic, but a diagnostic procedure for sessile gastric polyps. J Gastroenterol Hepatol. 2008. 23:551–5.
crossref
13.Kondo H., Saito D., Yamaguchi H., Shirao K., Watanabe Y., Ishido T, et al. Clinical follow-up and management of gastric benign/malignant borderline lesion. Stomach Intest. 1994. 29:197–204.
14.Kim YJ., Park JC., Kim JH., Shin SK., Lee SK., Lee YC, et al. Histologic diagnosis based on forceps biopsy is not adequate for determining endoscopic treatment of gastric adenomatous lesions. Endoscopy. 2010. 42:620–6.
crossref
15.Jung MK., Jeon SW., Park SY., Cho CM, Tak WY., Kweon YO, et al. Endoscopic characteristics of gastric adenomas suggesting carcinomatous transformation. Surg Endosc. 2008. 22:2705–11.
crossref
16.Takao M., Kakushima N: Takizawa K., Tanaka K., Yamaguchi Y., Matsubayashi H, et al. Discrepancies in histologic diagnoses of early gastric cancer between biopsy and endoscopic mucosal resection specimens. Gastric Cancer. 2012. 15:91–6.
crossref

Table 1.
Clinicopatholgical characteristics of the study subjects
Clinicopatholgical characteristics of 137 patients (141 lesions)
Age, years, median (range) 67 (41-89)
Sex, Male/Fcmale (%) 100/37 (73.0/27.0)
Lociition, n (%)  
  Upper (cardia, fundus, upper body) 12(8.5)
  Mid (mid body, lower body, angle) 51 (36.2)
  Lower (antrum, pylorus) 78 (55.3)
Lesion diameter, mm, median (range) 10(1-50)
Gross lypc, n (%)  
  Protruded 11 (7.8)
  Flat elevated 20(14.2)
  Flat 32 (22.7)
  Flat depressed 30 (21.3)
  Depressed or Ulcerative 4 (2.8)
  Combined 44 (31.2)
Biopsy pathology, group classification, n (%)  
  Non-adenomatous neoplasm 5 (3.5)
  Adeoma & CIS 65 (46.1)
  Adenocarcinoma & other cancers 71 (50.4)
Histological type of cancer, forceps biopsy, n (%)  
  WD 42 (59.2)
  MD 23 (32.4)
  PD 4(5.6)
  Other cancers (carcinoid tumor, mucinous carcinoma) 2(2.8)
Endoscopic resection method, n (%)  
  Endoscopic mucosal resection 27(19.1)
  Endoscopic submucosal dissection 114 (80,9)

CIS, carcinoma in situ: WD, well differentiated; MD, moderate differentiated; PD. poorly differentiated;

EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection.

Table 2.
Pathological differences between forceps biopsy specimens and endoscopic resection specimens
Forceps biopsy specimens Endoscopic resection specimens
  Non- adenomatous neoplasm Adenoma&CIS Adenocarcinoma Other cancers
WD MD PD
Non-adenomatous neoplasm (n=5) - - 1 1 1 2
Adenoma & CIS(n=65) - - 46 14 4 i
Adenocarcinoma (n 二 69) WD (n=42) 0 6 24 10 2 0
MD (n-23) 0 1 6 14 2 0
PD (n=4) 0 0 0 0 4 0
Other cancers (n=2) 0 0 0 0 0 2

CIS, carcinoma in situ; WD, well differentiated; MD, moderate differentiated; PD, poorly differentiated.

Table 3.
Analysis of the Predictable Factors of Pathological Differences between Non-cancer and Cancer after Endoscopic Resection
  Endoscopic resection specimens P-value
Non-cancer (n=84) Cancer (n=70)
Age      
  <65 50 (59.5%) 36 (51.4%) 0.16
  ≧ 65 34 (40.5%) 34 (48.6%)  
Sex      
  Male 60(71.4%) 49 (70.0%) 0.42
  Female 24 (28.6%) 21 (30.0%)  
Location      
  Upper 5 (6.0%) 7(10.0%) 0.18
  Mid 27(32.1%) 29 (41.4%) 0,12
  Lower 52(61.9%) 34 (48.6%) 0.05
Tumor size      
  <15 69(82.1%) 48 (68.6%) 0.03
  ≧ 15 15 (17.9%) 22 (31.4%)  
Depression      
  Present 12(14.3%) 29 (41.4%) <0,01
  Absent 72 (S5.7%) 41 (58.6%)  
Ulceration      
  Present 2 (2.4%) 13 (18.6%) <0.01
  Absent 82 (87.6%) 57(81.4%)  
Table 4.
Analysis of the Predictable Factors of Pathological Differences between Non- Poorlv Differentiated and Poorly Differentiated after Endoscopic Resection
  Endoscopic resection specimens P-value
Non-PD (n= 23) PD (n=9)
Age      
  <65 52 (42.3%) 2 (22.2%) 0.08
  ≧ 65 71 (57.7%) 7 (77.8%)  
Sex      
  Male 91 (74.0%) 6 (66.7%) 0.33
  Female 32 (26.0%) 3 (33.3%)  
Location      
  Upper 10(8,1%) 0 (0%)  
  Mid 43 (35.0%) 6 (66.7%) 0.03
  Lower 70 (56.9%) 3 (33.3%) 0,07
Tumor size      
  <15 81 (65.9%) 6 (66.7%) 0.48
  ≧15 42 (34.1%) 3 (33.3%)  
Depression      
  Present 62 (50.4%) 6 (66.6%) 0.16
  Absent 6i (49.6%) 3 (33.3%)  
Ulceration      
  Present 32 (26.0%) 2 (22.2%) 0.40
  Absent 91 (74.0%) 7 (77.8%)  

PD, poorly differentiated

TOOLS
Similar articles